Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment OF NON-MUSCLE Invasive Bladder Cancer. McElree IM, Packiam VT, Steinberg RL, Mott SL, et al. J Urol 2022 Jul 5:101097JU0000000000002848. doi: 10.1097/JU.0000000000002848.

Read + Share

Amedeo Smart

Independent Medical Education

McElree IM, Packiam VT, Steinberg RL, Mott SL, et al. Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment OF NON-MUSCLE Invasive Bladder Cancer. J Urol 2022 Jul 5:101097JU0000000000002848. doi: 10.1097/JU.0000000000002848.
PMID: 35830552